The impact of coronavirus disease 2019 (COVID-19) response on central-line–associated bloodstream infections and blood culture contamination rates at a tertiary-care center in the Greater Detroit area
Open Access
- 20 November 2020
- journal article
- research article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 42 (8) , 997-1000
Abstract
We conducted a comparative retrospective study to quantify the impact of coronavirus disease 2019 (COVID-19) on patient safety. We found a statistically significant increase in central-line–associated bloodstream infections and blood culture contamination rates during the pandemic. Increased length of stay and mortality were also observed during the COVID-19 pandemic.Keywords
This publication has 6 references indexed in Scilit:
- Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysisClinical Microbiology and Infection, 2020
- Priorities for the US Health Community Responding to COVID-19JAMA, 2020
- Central Line–Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National StudyInfection Control & Hospital Epidemiology, 2016
- Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line–associated bloodstream infectionsAmerican Journal of Infection Control, 2015
- Guidelines for the Prevention of Intravascular Catheter-related InfectionsClinical Infectious Diseases, 2011
- Long-term prognosis after peri-operative cardiac complicationsJournal of Clinical Epidemiology, 1994